| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/03/1998 | US5723129 GnRH-leukotoxin chimeras |
| 03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| 02/26/1998 | WO1998007864A1 Recombinant toxin fragments |
| 02/26/1998 | WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/25/1998 | EP0824590A1 Vasoactive intestinal peptide |
| 02/25/1998 | EP0824548A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 02/24/1998 | US5721352 Entomopoxvirus expression system |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis |
| 02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006845A1 Mammalian ribonuclease inhibitors and use thereof |
| 02/19/1998 | WO1998006749A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | WO1998006416A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
| 02/19/1998 | CA2263195A1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | CA2262524A1 Gnrh-leukotoxin chimeras |
| 02/19/1998 | CA2262427A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/18/1998 | EP0824150A2 Plant promoter and utilization thereof |
| 02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
| 02/17/1998 | US5718898 Monoclonal antibody or fragment thereof which specifically binds to gp200 of saccharomyces sensu stricto, but does not cross-react with any other species of yeast |
| 02/12/1998 | WO1998005789A2 Controlled gene expression in plants |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | CA2595037A1 Modified tie-2 receptor ligands |
| 02/12/1998 | CA2261574A1 Controlled gene expression in plants |
| 02/11/1998 | EP0823480A1 Controlled gene expression in plants |
| 02/11/1998 | EP0823438A2 Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 02/11/1998 | EP0822941A1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
| 02/11/1998 | EP0500734B1 Protein complexes having factor viii:c activity and production thereof |
| 02/10/1998 | US5717074 Macrophage-derived inflammatory mediator (MIP-2) |
| 02/10/1998 | US5717071 Culture product bactericide specific binding to lipopolysaccharide of outer membrane for treating bacterial infection |
| 02/05/1998 | WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 02/05/1998 | WO1998004576A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | WO1997033912A3 Uses of gdnf and gdnf receptor |
| 02/05/1998 | WO1997032891A3 Conjugate for modifying interactions between proteins |
| 02/05/1998 | CA2261164A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0506821B1 Hybrid protein c |
| 02/04/1998 | CN1172502A In vivo mutations and polymorphisms in 17 q -linked breast and ovarian cancer susceptibility gene |
| 02/03/1998 | US5714344 Protease-derivatized CVF |
| 02/03/1998 | CA1339654C Gene therapy using gene fusion for genetic or acquired disorders |
| 01/29/1998 | WO1998003189A1 Use of conantokins |
| 01/29/1998 | WO1997047732A3 Hexameric fusion proteins and uses therefor |
| 01/29/1998 | CA2261570A1 Use of conantokins |
| 01/28/1998 | EP0752886B1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/28/1998 | EP0474789B1 Cysteine thiol-protected peptides for use in immunoassays |
| 01/27/1998 | US5712122 Carboxy terminal peptide-extended proteins |
| 01/27/1998 | US5712121 Treatment of illnesses with demonstrated eosinophilia |
| 01/27/1998 | US5712120 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 01/27/1998 | US5712101 Glycosylation of hemoglobin, quantification, reaction with epitopes for detection of diabetes |
| 01/22/1998 | WO1998002559A1 Over-expression of proteins |
| 01/22/1998 | WO1998002541A1 Gamma-heregulin |
| 01/22/1998 | WO1998002540A1 Chimeric heteromultimer adhesins |
| 01/22/1998 | WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES |
| 01/22/1998 | WO1998002454A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2260288A1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies |
| 01/22/1998 | CA2258721A1 Chimeric heteromultimer adhesins |
| 01/22/1998 | CA2255683A1 Over-expression of proteins |
| 01/20/1998 | US5710017 DNA encoding a constitutive activator retinoic acid response (CAR) receptor |
| 01/20/1998 | US5709859 Complexes of fusion proteins; antitumor agent; antiinflammatory agents |
| 01/14/1998 | EP0818467A2 Aligned peptide array and a rational and rapid method for the detection of a binding or interaction site of a protein by using the same |
| 01/14/1998 | EP0817854A2 Antigen presentation system based on retrovirus-like particles |
| 01/13/1998 | US5708146 Antibodies and drugs |
| 01/13/1998 | US5708143 Protocadherin materials and methods |
| 01/13/1998 | US5707964 Hormone-toxin conjugate, gonadotropin-releasing hormone receptors |
| 01/13/1998 | US5707805 Assay for detecting keratinocyte growth factor (KGF) and its activity |
| 01/08/1998 | WO1998000546A2 Bacillus thuringiensis toxins active against noctuidae pests |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | CA2259142A1 Bacillus thuringiensis toxins active against noctuidae pests |
| 01/07/1998 | EP0816506A1 System for the expression of heterologous antigens as fusion proteins |
| 01/07/1998 | EP0815872A2 Compounds for targeting |
| 01/07/1998 | EP0815250A2 Control of floral induction in plants and uses therefor |
| 01/07/1998 | EP0815247A1 Method for the production of cationic peptides |
| 01/07/1998 | EP0815245A1 Bioactive fusion proteins and pre-existing tumor therapy |
| 01/07/1998 | EP0815140A1 Production in yeasts of stable antibody fragments |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0486572B1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | EP0406357B1 Functional recombinantly prepared synthetic protein polymer |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705484 Biologically active polypeptide fusion dimers |
| 01/06/1998 | US5705387 Heat-inducible N-degron module |
| 01/06/1998 | US5705364 Mammalian cell culture process |
| 01/06/1998 | US5705163 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049725A1 Modified factor viii |
| 12/31/1997 | WO1997035873A3 Peptides with antiproliferative properties |
| 12/30/1997 | US5703048 Hepatocyte growth factor |
| 12/30/1997 | US5703039 Chimeric toxins |
| 12/30/1997 | US5703038 Emhanced biological activity |
| 12/30/1997 | US5702704 Antibodies to in vivo advanced glycosylation endproducts |
| 12/30/1997 | CA1339606C Polypeptides complementary to peptides or proteins having an amino acid sequence or necleotide coding sequence at least partially known |
| 12/29/1997 | EP0814089A2 Respiratory syncytial virus: vaccines and diagnostic assays |
| 12/29/1997 | EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 12/29/1997 | EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders |